News Digging > Podcasts > New antibody therapy reveals promising phase I clinical trial results for advanced, treatment-refractory pediatric brain cancer
New antibody therapy reveals promising phase I clinical trial results for advanced, treatment-refractory pediatric brain cancer
New antibody therapy reveals promising phase I clinical trial results for advanced, treatment-refractory pediatric brain cancer,BOSTON – Effective and safe treatments are needed for medulloblastoma—the most common type of cancerous brain tumor in children—especially for

New antibody therapy reveals promising phase I clinical trial results for advanced, treatment-refractory pediatric brain cancer

BOSTON – Effective and safe treatments are needed for medulloblastoma—the most common type of cancerous brain tumor in children—especially for